Journal article
Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer
Abstract
INTRODUCTION: Treatment intensification beyond androgen deprivation therapy (ADT) has shown survival benefit in patients with metastatic castration-sensitive prostate cancer (mCSPC). There is a need to better understand how these novel treatments fit in real-world practice.
METHODS: Using electronic medical records and administrative data, a population-based, retrospective cohort study of patients diagnosed with de novo mCSPC between 2010 and …
Authors
Gotto GT; Yip SM; Shayegan B; O'Sullivan DE; Wallis CJD; Basappa NS; Cagiannos I; Hamilton RJ; Ferrario C; Fernandes R
Journal
Canadian Urological Association Journal, Vol. 19, No. 1, pp. e25–e35
Publisher
Canadian Urological Association Journal
Publication Date
January 2025
DOI
10.5489/cuaj.8691
ISSN
1911-6470